Delivery Order 75N93021D00018-75N93021F00001
Award Date
6/10/21
Potential Completion Date
6/9/22
Potential Value
$131K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Charles River Laboratories, Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC Category
AJ11 - General Science And Technology R&D Services; General Science And Technology; Basic Research
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Wilmington, MA 01887, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Charles River Laboratories, Inc. (doing business as Charles River), a global contract research organization, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract is for the provision of clinical trial materials for virus vaccines, with a ceiling value of $296,136.10 and a performance period through September 30, 2025. The contract is a delivery order and is priced on a firm...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the U.S. Department of Health and Human Services, awarded a firm fixed-price delivery order contract to Charles River Laboratories, Inc. (Charles River) to manufacture and safety test experimental virus vaccines. The contract has a ceiling value of $180,360.00 and runs through June 20, 2017. This award was not set aside for any socioeconomic program. As a leading provider of research-related products and...
This is a $525,975.60 firm-fixed-price delivery order contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Charles River Laboratories, Inc. for the provision of clinical trial materials for virus vaccines. The contract has a completion date of December 31, 2024 and was not set aside for any specific business type. Charles River Laboratories is a global provider of essential products and services to support drug discovery,...
Charles River Laboratories, Inc. was awarded a firm fixed price delivery order valued at four hundred fifty-two thousand eight hundred nine dollars and eighty cents ($452,809.80) by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The contract calls for Charles River to manufacture clinical trial material for respiratory syncytial virus vaccine candidates known as B/HPIV3/HMPV-F under lots PIV#115A and PIV#116. Performance will occur in Wilmington,...
<p>The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $403,774.50 firm fixed price delivery order contract to Charles River Laboratories, Inc., doing business as Charles River, for coronavirus challenge virus support. The contract will be performed in Wilmington, Massachusetts over a one year period from July 25, 2022 through July 24, 2023. No subcontractors were identified.</p>
This federal contract award, valued at $164,622.60, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Charles River Laboratories, Inc. for the manufacture and safety testing of experimental virus vaccines. The contract is a delivery order with a firm fixed price. Charles River Laboratories is a global contract research organization that provides a wide range of research-related products and services to government agencies, including laboratory animals, diagnostic...
This is a firm-fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Charles River Laboratories, Inc. (Charles River) to manufacture and safety test experimental virus vaccines. The contract has a ceiling value of $178,790.70 and a completion date of January 11, 2016. This order was placed under an existing indefinite delivery contract with Charles River, likely to support NIAID's ongoing...
This is a federal delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Charles River Laboratories, Inc. for the provision of clinical trial materials for virus vaccines. The contract has a ceiling value of $374,769.10 and a period of performance ending on September 30, 2025. It is a firm fixed-price contract with no set-aside designation. Charles River Laboratories is a global contract...
This $186,389.10 firm fixed-price delivery order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Charles River Laboratories, Inc. to manufacture and safety test experimental virus vaccines. The contract, which does not have a set-aside designation, was awarded on February 10, 2015 with an ultimate completion date of August 9, 2016. Charles River Laboratories is a global contract research organization...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $21,208 firm fixed price purchase order to Charles River Laboratories, Inc. for branded test cartridges. Charles River will deliver CHARLES RIVER LABORATORIES INC. BRANDED TEST CARTRIDGES (AMBIS #2181580) under the contract, to be performed in Wilmington, Massachusetts between September 15, 2023 and October 27, 2023. As the National Institute of Allergy and...